Zydus DNA vaccine candidate against SARS-CoV-2, ZyCoV-D is the world’s first and India’s indigenously developed Plasmid DNA vaccine to be administered in humans including children and adults 12 years and above.
Benefits
The plug and play technology on which the plasmid DNA platform is based can be easily adapted to deal with mutations in the virus, such as those already occurring.
Accessibility Controls
